Creative Medical Technology Holdings, Inc. (CELZ)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $0.82
- As of
Kresmion compiles this page from CELZ's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-25.
See the full CELZ dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for CELZ on one page. Preview it with sample data, then open it live with a free account.
Preview the CELZ dossierActive signals for CELZ
- mediumEARNINGS_MISS
Q4-2025: Missed consensus by 93.4% - EPS $-0.73 vs $-0.3774 estimate
- mediumEARNINGS_MISS
Q1-2025: Missed consensus by 56.5% - EPS $-0.83 vs $-0.5304 estimate
- mediumEARNINGS_BEAT
Q2-2025: Beat consensus by 25.3% - EPS $-0.48 vs $-0.6426 estimate
FREE, NO ACCOUNT
Every signal on CELZ, as it fires
New filings, 13F moves and cross asset signals on CELZ land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Recent SEC filings, CELZ
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
CELZ against its peers
CELZ's operating margin of -102380.2% ranks in the 4th percentile of 11 Biotechnology sub-industry peers, fiscal periods ending between 2025-06-30 and 2026-04-30.
| Metric | CELZ | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 6000 USD | 555462 USD | 23 | 14 |
| Revenue YoY | n/a | -30.9% | n/a | 6 |
| Gross margin | 63.4% | 64.8% | 42 | 5 |
| Operating margin | -102380.2% | -469.3% | 4 | 11 |
| Net margin | -99916.8% | -433.7% | 4 | 11 |
| Return on equity | -79.8% | -163.5% | 82 | 18 |
| 1 year | -76.0% | -79.6% | 66 | 15 |
Peers (21): CSCIF, RVPH, ALZN, CANF, AAGH, CLGN, EVGN, IMNN, XCUR, APRE, BOLT, KPTI, ACXP, AIM, LEXX, KALA, BGMS, PULM, SKYE, CDIO, CURX. Left out: LIANY (no annual filing), ENVB (no annual filing), ADAPY (no annual filing), NRSN (no annual filing). Fiscal periods ending between 2025-06-30 and 2026-04-30. Every figure is one full fiscal year read from one annual filing (CELZ: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow CELZ on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to CELZ for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.